New functions of integrin and talin discovered by an international research network

January 12, 2021

Researchers at Tampere University, Finland, have published new results in collaboration with an international research network that help to understand the biological phenomena mediated by cell membrane integrin receptors and contribute to the development of methods for the treatment of cancer.

In the cell membrane, integrins form the connection between the cytoskeleton and the extracellular matrix. The regulation of integrin activity is essential for the function of tissues and individual cells.

The studies investigated the structure and function of talin, a cytoskeletal protein, which is important in the regulation of the integrin receptor activity. Talin binds to integrin via its "head" and connects it to the cytoskeleton, thereby acting as a part of the cellular mechano-signalling network, which affects cell adhesion, migration, but also gene expression among other things.

One of the studies now published used X-ray crystallography to reveal the atomic structure of talin "head", giving unprecedented insights how talin binds to integrins.

"The activation of integrins mediated by talin is essential in various cancers, for example, and knowing the detailed structure of talin opens up new possibilities to combat cancer by developing inhibitors that prevent the interaction of talin and integrin," says Professor Vesa Hytönen from Tampere University.

The structure of talin was discovered in a group led by Professor Jinhua Wu (Fox Chase Cancer Center, PA, USA), and a research group at Tampere University led by Professor Vesa Hytönen was responsible for the biophysical characterizations in the study, while the cell-biological consequences were studied at the University of Geneva, Switzerland in a research group headed by Professor Bernhard Wehrle-Haller. The results were published in the Proceedings of National Academy of Sciences (PNAS).

The significance of the structure of talin for integrin activation gained new perspectives in Sampo Kukkurainen's doctoral dissertation, which used molecular dynamics simulations to study the interaction of the talin - integrin pair.

The multidisciplinary research project related to Kukkurainen's dissertation project was also carried out in close collaboration with the research group of Professor Bernhard Wehrle-Haller (University of Geneva, Switzerland) and involved several research groups from Europe and the United States, including Professor Janne Jänis's research group at the University of Eastern Finland and Research Director Markku Varjosalo's and Professor Ilpo Vattulainen's research groups at the University of Helsinki. The results were published in the Journal of Cell Science.

The study provided new detailed information on the mechanism of protein interaction.

"The study showed that the loop of the F1 subunit of talin is essential for the activation of integrins," says Dr. Kukkurainen.

At Tampere University, doctoral researcher Latifeh Azizi is currently investigating how the mutation of talin affects protein function.

An article related to Azizi's study published in Scientific Reports showed how mutations observed in cancer patients affect the structure, interactions, and biological activity of talin in cells. The study was conducted in collaboration with a research group led by Dr. Ben Goult (University of Kent, UK). The mutations selected for the study were screened from sequence databases using structural data and bioinformatics methods.

"It was interesting to find that a single mutation in a large protein can affect cell function so much," says Azizi.

The study showed that talin mutations affect cell motility and cell communication. The research result is a step towards personalised medical treatments in which information from a cancer patient's tumour can be used to select an appropriate treatment.
The studies used the scientific computing services provided by the CSC - IT Center for Science and the EU's Prace programme, the research facilities of EMBL (European Molecular Biology Laboratory) and the services of Biocenter Finland.

The research group led by Professor Hytönen is funded by the Academy of Finland, the Sigrid Jusélius Foundation and the Cancer Foundation Finland, among others. Latifeh Azizi has received financial support from the Anu Kirra Foundation, the University of Tampere Foundation and the Doctoral Programme in Medicine, Life Sciences and Biomedical Engineering at Tampere University.

Tampere University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to